GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bionik Laboratories Corp (OTCPK:BNKL) » Definitions » Shiller PE Ratio

Bionik Laboratories (Bionik Laboratories) Shiller PE Ratio : (As of Jun. 01, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Bionik Laboratories Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Bionik Laboratories Shiller PE Ratio Historical Data

The historical data trend for Bionik Laboratories's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionik Laboratories Shiller PE Ratio Chart

Bionik Laboratories Annual Data
Trend Dec14 Dec15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bionik Laboratories Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Bionik Laboratories's Shiller PE Ratio

For the Medical Care Facilities subindustry, Bionik Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bionik Laboratories's Shiller PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bionik Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bionik Laboratories's Shiller PE Ratio falls into.



Bionik Laboratories Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Bionik Laboratories's E10 for the quarter that ended in Mar. 2023 is calculated as:

For example, Bionik Laboratories's adjusted earnings per share data for the three months ended in Mar. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-0.2/127.3478*127.3478
=-0.200

Current CPI (Mar. 2023) = 127.3478.

Bionik Laboratories Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201306 0.000 98.518 0.000
201309 0.000 98.790 0.000
201312 -0.024 98.326 -0.031
201403 -0.338 99.695 -0.432
201406 -1.500 100.560 -1.900
201409 -3.000 100.428 -3.804
201412 21.661 99.070 27.844
201503 -20.999 99.621 -26.843
201506 -3.000 100.684 -3.794
201509 -3.000 100.392 -3.806
201512 3.000 99.792 3.828
201603 -1.500 100.470 -1.901
201606 -4.500 101.688 -5.636
201609 -3.000 101.861 -3.751
201612 -3.000 101.863 -3.751
201703 -6.000 102.862 -7.428
201706 -3.000 103.349 -3.697
201709 -5.356 104.136 -6.550
201712 -3.800 104.011 -4.653
201803 -8.990 105.290 -10.873
201806 -0.440 106.317 -0.527
201809 -1.620 106.507 -1.937
201812 -0.910 105.998 -1.093
201903 -1.330 107.251 -1.579
201906 -0.550 108.070 -0.648
201909 -0.870 108.329 -1.023
201912 -0.580 108.420 -0.681
202003 -3.620 108.902 -4.233
202006 -0.390 108.767 -0.457
202009 -0.320 109.815 -0.371
202012 -1.750 109.897 -2.028
202103 -0.200 111.754 -0.228
202106 -0.080 114.631 -0.089
202109 -0.220 115.734 -0.242
202112 -1.180 117.630 -1.277
202203 -0.290 121.301 -0.304
202206 -0.200 125.017 -0.204
202209 -0.160 125.227 -0.163
202212 -0.160 125.222 -0.163
202303 -0.200 127.348 -0.200

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bionik Laboratories  (OTCPK:BNKL) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Bionik Laboratories Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Bionik Laboratories's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bionik Laboratories (Bionik Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
80 Coolidge Hill Road, Watertown, MA, USA, 02472
Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and innovative robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.
Executives
Remi Gaston-dreyfus director, 10 percent owner 46 RUE PIERRE CHARRON, PARIS I0 75008
Charles Matine director 7 RUE GUSTAVE, FLAUBERT, PARIS I0 75017
Andre-jacques Auberton-herve director, officer: Chairman 18 CHEMIN DE LA VIERGE NOIRE, LA TRONCHE I0 38700
Daniel Gonsalves officer: Executive Vice President & CFO 80 COOLIDGE HILL ROAD, WATERTOWN MA 02472
Loren W. Wass officer: See Remarks 34 HOG HILL ROAD, PEPPERELL MA 01463
Joseph R Martin director
Audrey Thevenon director 4500 WESTBROOK LANE, KENSINGTON MD 20895
Peter Gerald Malone director
Russo Richard Paul Jr officer: Chief Financial Officer 20 PLUNKETT WAY, TEWKSBURY MA 01876
Renaud Bertrand Maloberti officer: Chief Commercial Officer 10 ACORN WAY, GEORGETOWN MA 01833
Timothy A. Mccarthy officer: Chief Commercialization Office C/O BIONIK, 483 BAY STREET, N105, TORONTO A6 M5G 2C9
Eric Michel Dusseux director 1 RUE DU CAPOT, CALUIRE-ET-CUIRE I0 69300
Jules Marc Fried officer: VP - U.S. Operations C/O INTERACTIVE MOTION TECHNOLOGIES INC., 80 COOLIDGE HILL ROAD, WATERTOWN MA 02472
Hermano Igo Krebs officer: Chief Science Officer C/O INTERACTIVE MOTION TECHNOLOGIES INC., 80 COOLIDGE HILL ROAD, WATERTOWN MA 02472
Marc Mathieu director 716 BROOKS AVENUE, VENICE CA 90291